Daré Bioscience Highlights Revenue Opportunity as CEO Discusses Upcoming Launch of Flora Sync LF5™ in Virtual Investor “What This Means” Segment
Go back to Daré Bioscience Highlights Revenue Opportunity as CEO Discusses Upcoming Launch of Flora Sync LF5™ in Virtual Investor “What This Means” Segment| (NASDAQ: DARE) | Delayed: 0.72 +0.01 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.71 | 52 Week High | $ | |||
| Open | $0.70 | 52 Week Low | $ | |||
| Day High | $0.76 | P/E | N/A | |||
| Day Low | $0.70 | EPS | $ | |||
| Volume | 437,484 | |||||
| (NASDAQ: DARE) | Delayed: 0.72 +0.01 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.71 | 52 Week High | $ | |||
| Open | $0.70 | 52 Week Low | $ | |||
| Day High | $0.76 | P/E | N/A | |||
| Day Low | $0.70 | EPS | $ | |||
| Volume | 437,484 | |||||

